Introduction: Two methods were compared for evaluating the sigma metrics of clinical biochemistry tests using two different allowable total error (TEa) specifications.
| INTRODUC TI ON
Sigma (σ) metric was first introduced into clinical laboratories by David Nevalainen 1 in 2000. The practice of using the σ to improve clinical laboratory quality has been in place for nearly two decades. 2 Sigma metric has become a useful tool to monitor quality indicators, 1 to assess the analytical quality of assays, 3, 4 to set quality control rules, [5] [6] [7] [8] to describe assay analytical performance for external quality assessment participants, 9 and to help manufacturers choose product requirements. 10 Analytical quality of assays is quantitatively estimated as a sigma metric based on 3 parameters: allowable total error (TEa), bias, and imprecision. The TEa from various sources, such as the Clinical Laboratory Improvement Amendments (CLIA), the College of American Pathologists (CAP), Reference Institute for Bioanalytics (Rilibak), the Royal College of Pathologists of Australasia (RCPA), and the China National Center for Clinical Laboratories (NCCL) external quality assessment goals, is associated with significantly different Sigma metrics for the same assay. 8, 11 Thus, laboratories have to take into account which TEa specification is most appropriate initially.
Imprecision is usually presented as the standard deviation (SD) or coefficient of variation (CV). CV (SD) and bias often vary with the concentration of analytes, so the σ computed at different QC concentration levels could be quite different from one another. 12 Previous studies have reported that individual assays' biases were calculated by comparing their mean with the statistical target mean in external quality assessment (EQA) survey reports, 13, 14 but the statistical target mean was derived from statistical results, which did not have measurement traceability. Additionally, if the concentration of IQC materials differed significantly from that of EQA samples, the σ calculation may not represent the optimal quality of the analytes. On the other hand, the target means in trueness verification proficiency testing was determined by the reference methods. Therefore, the bias and imprecision from this approach were more convincing. 12 Laboratories using commercial quality control could upload the IQC data to the inter-laboratory comparison database and compare these data with the target mean of the peer group to calculate bias and CV. The internal quality control data inter-laboratory comparison-based approach has been shown to be a convenient and reliable method among clinical laboratories. Xinqi Cheng et al 15 introduced two approaches to compute bias and CV for σ evaluation, using a proficiency testing (PT) or an internal quality control (IQC)-based approach. Herein, we take similar approaches. 1 For the trueness verification proficiency testing (TPT)-based approach, bias was calculated by comparing the measured mean with the target mean derived from the measured results of the reference measurement procedure provided by the China National Center for Clinical Laboratories (NCCL), and the CV was calculated by testing the analytes five times daily for 3 days for each TPT sample according to the instructions from the Chinese NCCL 2 ; for the internal quality control data inter-laboratory comparison (IQC)-based approach, bias was calculated by comparing the measured mean with the target mean of the global peer group, and CV was calculated with the IQC results. Based on both approaches, the bias and CV of the analyte could be acquired simultaneously at the same concentration, rather than being synthetically calculated at different concentrations. We introduced this study to compare both approaches for bias and CV calculations and to determine the effects of these approaches on σ evaluation at two TEa specifications.
| MATERIAL S AND ME THODS

| Materials
Nineteen assays were tested using the manufacturer's original reagents and calibrators on the Siemens Advia 2400 system (Siemens Healthcare Diagnostics Inc) in Beijing Tsinghua Changgung Hospital.
The reference method/material traceability of the assays is shown in 
| Methods
| Sample preparation
All the TPT samples from the Chinese NCCL were prepared from pooled fresh human serum. Each level, with 3 separate aliquots, was frozen and stored at −70°C until shipment on dry ice to our laboratory. The samples were stored in the freezer at −70°C as soon as they were received until use. When testing, the samples were placed at room temperature for 20 minutes and then gently mixed until completely dissolved and assayed in our laboratory within 4 hours.
| Bias calculation
For the TPT-based approach, the target value of each level of nineteen analytes of TPT samples was assigned by the reference laboratories organized by the Chinese NCCL, following the recommended reference measurement procedures. [16] [17] [18] The aliquot of each level was measured on 3 specific days, and each aliquot was tested under repeatability condition five times referring to the procedure of CLSI EP15-A2. 19 Thus, a total of 15 results were obtained for each concentration level. The average of the 15 results was considered as the laboratory-tested value.
All the results were reported to the online EQA platform developed by the Chinese NCCL (www.nccl.org.cn), and a summary report of the evaluation results can also be acquired on the online EQA platform. 16, 18 Bias was determined as (our mean − target mean)/target mean × 100%. Bias was calculated as (our mean − mean of peer group)/ mean of peer group × 100%. 15 
| Imprecision evaluation
Imprecision in this study was determined for each level of 19 analytes of TPT samples using the 15 results according to the formula defined in CLSI guideline EP15-A2 19 for the TPT-based approach. 18 Bio-Rad Liquid Assayed Multiqual controls were assayed daily for the nineteen analytes and calculated with the IQC results for the IQC-based approach. 
| Sigma calculation
The two TEa requirements, USA Clinical Laboratory Improvement was used for data analysis and graphing.
| RE SULTS
| Sigma metrics from TPT-based approach
Sigma metrics of 19 assays computed by the TPT-based approach and IQC-based approach using two TEa requirements (σ CLIA and σ WS/T ) are listed in Table 2 . The TEa CLIA used absolute bias for K, Na, and Ca assays, whereas TEa WS/T used percentage bias and was stricter than TEa CLIA . Among the 19 assays by a TPT-based approach, 16 assays showed σ CLIA > 3, 10 assays (GLU, CREA, K, Cl, LDH, CK, AMY, ALP, TC, and TG) showed σ CLIA > 6, and 3 assays (UN, ALT, and GGT) showed σ CLIA < 3. On the other hand, 12 assays showed σ WS/T > 3, 8 assays (CREA, Na, K, Cl, LDH, CK, AMY, and ALP) showed σ WS/T > 6, and 6 assays (UN, UA, Ca, Mg, ALT, and GGT) showed σ WS/T < 3. σ CLIA > σ WS/T in 18 out of 19 assays (all except Na).
| Sigma metrics from IQC-based approach
Sigma metrics of 19 assays computed by the IQC-based approach using two TEa requirements (σ CLIA, σ WS/T ) are shown in Table 2 . For the IQC-based approach, 19 and 16 assays showed σ CLIA > 3 (GLU, CREA, UA, K, Mg, Cl, ALT, AST, GGT, LDH, CK, AMY, ALP, and TG exceeded 6σ levels) and σ WS/T > 3 (UA, Na, K, Mg, Cl, AST, LDH, AMY, ALP, TC, and TG exceeded 6σ levels), respectively. Similar to the TPT-based approach, σ CLIA > σ WS/T for all assays except Na.
| Comparative analysis of sigma metrics between both methods
Nine analytes (GLU, CREA, K, Cl, LDH, CK, AMY, ALP, and TG) had a σ CLIA above 6, and 6 analytes (Na, K, Cl, LDH, AMY, and ALP) had a σ WS/T above 6 from both methods, which is actually effectively in agreement.
As shown in Figure 1 , the σ CLIA and σ WS/T derived from both methods for nineteen analytes were significantly different. For instance, the σ CLIA for the TPT-based approach vs the IQC-based approach of UN at similar concentration levels was 12 Abbreviations: ALP, alkaline phosphatase, U/L; ALT, alanine aminotransferase, U/L; AMY, amylase, U/L; AST, aspartate aminotransferase, U/L; Ca, calcium, mmol/L; CK, creatine kinase, U/L; Cl, chloride, mmol/L; CREA, creatinine, µmol/L; CV, coefficient of variation; GGT, gamma-glutamyltransferase, U/L; GLU, glucose, mmol/L; K, potassium, mmol/L; LDH, lactate dehydrogenase, U/L; Mg, magnesium, mmol/L; Na, sodium, mmol/L; TC, total cholesterol, mmol/L; TEaCLIA, allowable total error derived from USA Clinical Laboratory Improvement Amendments of 1988 (CLIA '88); TEaWS/T, allowable total error derived from the People's Republic of China Health Industry Standard (WS/T 403-2012); TG, triglycerides, mmol/L; TP, total protein, g/L; UA, uric acid, µmol/L; UN, urea nitrogen, mmol/L. a σ is calculated by using absolute bias as the allowable total error (TEa), not marked indicates using percentage bias to calculate the σ. b σ < 3. c σCLIA and σWS/T were compared at similar concentration levels for each assay using TPT-based method and IQC-based method.
TA B L E 2 (Continued)
3.48 (45792), respectively. The σ CLIA and σ WS/T comparisons at similar concentration levels for both methods are shown in Table 2 .
| D ISCUSS I ON
Six Sigma and analytical sigma metrics are a widely accepted measure of assessing method quality, optimizing QC procedures, and processing improvement. 2, 7 The sigma metrics computed at different concentration levels can be quite different from one another.
Another challenge in calculating sigma metrics is how to acquire the appropriate TEa, bias, and CV (SD). Therefore, this study was introduced to explore the comparative analysis of sigma metrics computed by both methods.
There are different TEa quality requirements for routine chemistry, 20 and the optimal TEa quality requirements should be established state-of-the-art. 21 It provides a feasible model for standardizing protocols and is being introduced to encourage all laboratories to use the same quality goals for their sigma metrics benchmarks. 22 Because TEa WS/T was more stringent than TEa CLIA for the most analytes, the σ WS/T was significantly lower than that of σ CLIA in 18 out of 19 assays (all except Na). Therefore, the limitation of selecting an appropriate TEa requirement for σ calculation should be considered.
Bias is an estimate of systematic measurement error. 23 Assessing bias can be challenging, and bias evaluation can significantly impact the sigma metrics. Bias is always evaluated using the following methods. 8 (a) The optimal method is to compare results obtained from fresh human specimens using the measurement procedure and a reference measurement procedure. In this study, we used fresh frozen human serum samples provided by trueness verification proficiency testing program from the Chinese NCCL.
The target means of nineteen analytes were determined using the corresponding reference measurement procedure from the Chinese NCCL. Samples derived from human serum could avoid the matrix effect, which was caused by the interaction of processed material and the measurement procedure and may suggest that erroneous results are being generated when in fact the results are acceptable. 24 The use of fresh frozen human specimens could avoid the matrix-related bias. 25 procedures. We used six months of IQC data to obtain relatively stable results. By contrast, the TPT-based approach may lead to a lower CV and an overestimated σ value because of the short-term assessment. 15 We further studied the QC rule design based on the sigma metrics of nineteen analytes designed based on sigma metrics by both methods using two TEa standards (data not shown in this study). The differences in QC rules, QC numbers, and QC run sizes as calculated using both approaches and two TEa standards were analyzed. The QC setting of nineteen analytes was compared test by test, that of seven analytes were the same and twelve analytes were different.
QC rules based on TEa ws/t were more stringent than that based on TEa CLIA . We are working on the adjustment of the individualized QC plan of the analyte based on its sigma metric evaluation.
One weakness of this study is that the imprecision evaluation following the Chinese NCCL instruction by the TPT approach (analyze five replicate samples at each of different concentrations daily for 3 days to obtain 15 results) was not conducted strictly according to the method described in the CLSI guideline EP15-A2 document (analyze one run per day with 3 replicate samples at each of different concentrations daily for 5 days to obtain 15 results) and CLSI guideline EP5-A3 (analyze two replicate samples at each of different concentrations daily for 20 days to obtain 40 results). 28 The TPT approach only lasted 3 days, which may have underestimated the imprecision. 18 The numbers of laboratories for the Bio-Rad IQC method from peer group comparison ranged between 5 and 50, and there may be increased imprecision due to the small number of laboratories. The concentration of analytes of the IQC materials differed significantly from that of the TPT samples, which may contribute to the differences in the calculation of σ based on both methods. Moreover, the research results may encourage the application of different methods for sigma evaluation, without the cost of high maintenance of commercial QC materials.
In conclusion, a combination of the TPT-based and IQC-based approach using NCCL and CLIA TEa goals may be adopted as the useful approaches for sigma metrics evaluation in clinical laboratories. When applying sigma metrics for Six Sigma management or quality control, sigma metrics should be evaluated comprehensively by different approaches. 
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